← Back to all recalls
DRUG RECALLMODERATE
Pemetrexed for Injection 100mg/Vial
Reliance Life Sciences recalls Pemetrexed for Injection 100mg/Vial over cGMP deviations.
What to do
Check your inventory for the recalled product with NDC 70069-0834-01. Stop using and return to the place of purchase or contact Reliance Life Sciences for a refund or replacement.
Why it was recalled
Reliance Life Sciences is recalling Pemetrexed for Injection 100mg/Vial due to cGMP deviations, which may affect product sterility or potency.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Recall # |
|---|---|
| Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01 | D-0672-2026 |
| Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01 | D-0673-2026 |
| Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01 | D-0674-2026 |
| Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01 | D-0671-2026 |
Where it was sold
Distributed nationwide.
Official source
← Back to all recalls
Editorial summary by Recall Canary · last updated 2026-07-28 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification